Key stats
About Direxion Daily Healthcare Bull 3X Shares
Expense ratio
0.96%
Home page
Inception date
Jun 15, 2011
As a levered product, CURE is not a buy-and-hold ETF, it's a short-term tactical instrument. Like many levered funds, it delivers 3x exposure only for one day. Over longer periods, returns can vary significantly from 3x of its underlying index, which covers some of the biggest healthcare nameslike J&J, Pfizer, and Merckin the space, and those heavyweights comprise a large share of CURE's cap-weighted, S&P 500-only portfolio. As a short-term product, CURE's expense ratio is less important than all in trading costs. Trading can be volatile. Check the latest Tradability data on this page.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Cash
Stocks77.85%
Health Technology61.23%
Health Services13.25%
Distribution Services2.36%
Retail Trade0.86%
Commercial Services0.15%
Bonds, Cash & Other22.15%
Cash22.15%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history